Organoclick (Sweden) Probability of Future Stock Price Finishing Over 3.0

ORGC Stock  SEK 2.73  0.09  3.19%   
Organoclick's future price is the expected price of Organoclick instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Organoclick AB performance during a given time horizon utilizing its historical volatility. Check out Organoclick Backtesting, Organoclick Valuation, Organoclick Correlation, Organoclick Hype Analysis, Organoclick Volatility, Organoclick History as well as Organoclick Performance.
  
Please specify Organoclick's target price for which you would like Organoclick odds to be computed.

Organoclick Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organoclick for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organoclick AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Organoclick AB generated a negative expected return over the last 90 days
Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M.
Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders

Organoclick Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Organoclick Stock often depends not only on the future outlook of the current and potential Organoclick's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organoclick's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding95.9 M
Cash And Short Term Investments34.2 M

Organoclick Technical Analysis

Organoclick's future price can be derived by breaking down and analyzing its technical indicators over time. Organoclick Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Organoclick AB. In general, you should focus on analyzing Organoclick Stock price patterns and their correlations with different microeconomic environments and drivers.

Organoclick Predictive Forecast Models

Organoclick's time-series forecasting models is one of many Organoclick's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Organoclick's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Organoclick AB

Checking the ongoing alerts about Organoclick for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Organoclick AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Organoclick AB generated a negative expected return over the last 90 days
Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M.
Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders

Additional Tools for Organoclick Stock Analysis

When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.